Global Psychedelic Drugs Market – Industry Trends and Forecast to 2031

Настройте свой отчет Настройте свой отчет Купить сейчас Купить сейчас Бесплатный пример отчета Бесплатный пример отчета
Дом Pharmaceutical Global Psychedelic Drugs Market
Запрос на TOC Запрос на TOC Обратиться к аналитику Обратиться к аналитику Купить сейчас Купить сейчас Узнать перед покупкой Узнать перед покупкой Бесплатный пример отчета Бесплатный пример отчета

Global Psychedelic Drugs Market – Industry Trends and Forecast to 2031

  • Pharmaceutical
  • Upcoming Report
  • Apr 2024
  • Global
  • 350 Pages
  • Количество таблиц: 220
  • Количество рисунков: 60
Купить сейчасКупить сейчас

Global Psychedelic Drugs Market

Размер рынка в млрд долларов США

CAGR :  % Diagram

Diagram Прогнозируемый период
 2024 –2031
Diagram Размер рынка (базовый год)
 USD 2.71 Billion
Diagram Размер рынка (прогнозируемый год)
 USD 7.35 Billion
Diagram CAGR
 %
Diagram Основные игроки рынка
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Запрос на разблокировку

Global Psychedelic Drugs Market, By Source (Synthetic and Natural), Type (Empathogens, Dissociatives, and Others), Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin, Lysergic Acid Diethylamide (LSD), 3,4-MethylEnedioxyMethamphetamine, and Others), Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder, and Others), Route of Administration (Oral, Inhalation, and Injectable), End-User (Hospitals, Specialty Clinics, Homecare, and Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, and Online Pharmacy) – Industry Trends and Forecast to 2031.

Psychedelic Drugs Market

Psychedelic Drugs Market Analysis and Size

The market for psychedelic drugs includes a range of substances classified as empathogens, dissociatives, and others. Empathogens such as MDMA can increase feelings of empathy and sociability, while dissociatives such as ketamine can create a sense of detachment from reality. Other psychedelics, such as psilocybin mushrooms and LSD, can change perception and cognition.

The global psychedelic drugs market size was valued at USD 2.71 billion in 2023 and is projected to reach USD 7.35 billion by 2031, with a CAGR of 13.3% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation       

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Source (Synthetic and Natural), Type (Empathogens, Dissociatives, and Others), Drugs (Gamma-Hydroxybutyric Acid, Ketamine, Psilocybin, Lysergic Acid Diethylamide (LSD), 3,4-MethylEnedioxyMethamphetamine, and Others), Application (Narcolepsy, Treatment Resistant Depression, Major Depressive Disorder, Opiate Addiction, Post-Traumatic Stress Disorder, and Others), Route of Administration (Oral, Inhalation, and Injectable), End-User (Hospitals, Specialty Clinics, Homecare, and Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, and Online Pharmacy)

Countries Covered

U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America

Market Players Covered

Jazz Pharmaceuticals, Inc. (U.S.), Janssen Pharmaceuticals, Inc. (U.S.), Hikma Pharmaceuticals PLC (U.K.), Compass (U.S.), Verrian (Germany), Pfizer Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Avadel (Ireland), Celon Pharma SA (Poland), Cybin Corp. (Canada), GH Research (Ireland), Entheon Biomedical Corp (Canada), PharmaTher Holdings Ltd. (India), NRx Pharmaceuticals, Inc. (U.S.), and Usona Institute (U.S.)

Market Opportunities
  • Increasing Research Funding
  •  Collaborations Between Academia and Industry

Market Definition

Psychedelic drugs are substances that can cause changes in perception, mood, and cognition, often resulting in intense subjective experiences. Instances of these compounds include psilocybin (found in certain mushrooms), LSD, and MDMA. They mainly target serotonin receptors in the brain and are under investigation for their potential therapeutic benefits in treating mental health disorders, especially when used in supervised settings.                    

Psychedelic Drugs Market Dynamics

Drivers

  • Rising Support for Psychedelic Therapy

The healthcare sector is increasingly accepting psychedelic therapy, spurred by numerous clinical trials demonstrating the therapeutic promise of substances such as psilocybin and MDMA for conditions such as depression, PTSD, and addiction. This evolving attitude among healthcare professionals and regulatory bodies is facilitating the wider incorporation of psychedelic-assisted therapy into conventional healthcare approaches, fueling substantial market expansion.

  • Worldwide Shift Towards Psychedelic Legalization and Decriminalization 

Governments around the world are reassessing their policies on psychedelics, acknowledging their therapeutic potential in treating mental health disorders.This shift includes moves to decriminalize possession and even legalize medical and recreational use. These policy changes are creating new opportunities for research, development, and commercialization in the market and driving the market growth.

Opportunities

  • Collaborations Between Academia and Industry

Academic institutions contribute scientific research and expertise, while industry partners provide resources and insights for drug development, formulation, and commercialization. This collaboration accelerates scientific discoveries into innovative therapies, offering lucrative opportunities for both sectors amidst growing market demand.

  • Increasing Research Funding

Rising research funding facilitates extensive scientific investigations into therapeutic applications, safety profiles, and mechanisms of action of psychedelic compounds. This financial support fosters the identification of novel drug candidates and enhances existing treatments, attracting public and private investments and fueling market growth and expansion.

Restraints/Challenges

  • Cultural Obstacles

In areas dominated by conservative values or where the use of psychedelic drugs contradicts cultural norms or religious beliefs, the acceptance of these substances may be limited. This lack of acceptance could lead to reduced demand for psychedelic therapies, decreased willingness among healthcare professionals to prescribe them, and difficulties in regulatory approval processes, which can be a challenge for the market. 

  • Misuse and Public Safety Issues

Misuse, whether recreational or self-administered without medical supervision, can lead to adverse effects such as psychological distress or worsening of underlying mental health conditions. These events lead to doubt among regulators, healthcare professionals, and the public, disrupting the widespread acceptance of psychedelic therapies.

This psychedelic drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the psychedelic drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In September 2023, Cybin Inc. revealed a strategic partnership with Fluence, a renowned provider of continuing education in psychedelic therapy. This collaboration aims to bolster the expansion of the EMBARK training program for the CYB003 phase 3 trial
  • In October 2022, Numinus Wellness Inc., a leading mental health care company, launched a pioneering program offering Ketamine for treating chronic and serious medical conditions. Initially, this groundbreaking program was introduced in Numinus' clinics situated in Utah, British Columbia, and Quebec

Psychedelic Drugs Market Scope

The psychedelic drugs market is segmented on the basis of source, type, drugs, application, route of administration, end-user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Source

  • Synthetic
  • Natural

Type

  • Empathogens
  • Dissociatives
  • Others

Drugs

  • Gamma-Hydroxybutyric Acid
  • Ketamine
  • Psilocybin
  • Lysergic Acid Diethylamide (LSD)
  •  3,4-MethylEnedioxyMethamphetamine
  • Others

Application

  • Narcolepsy
  • Treatment Resistant Depression
  • Major Depressive Disorder
  • Opiate Addiction
  • Post-Traumatic Stress Disorder
  • Others

 Route of Administration

  • Oral
  • Inhalation
  • Injectable

End-User

  • Hospital
  • Speciality Clinics
  • Homecare
  • Others

 Distribution Channel

  • Hospitals Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Psychedelic Drugs Market Regional Analysis/Insights

The psychedelic drugs market is analyzed and market size insights and trends are provided by country, source, type, drugs, application, route of administration, end-user, and distribution channel as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.

North America is expected to dominate the market due to the region's high prevalence of mental disorders, and ongoing research and development efforts drive market growth. This sustained leadership highlights North America's crucial role in influencing the direction of the global psychedelic drugs market.

Asia-Pacific is expected to witness significant growth during the forecast period due to expanding healthcare infrastructure and growing public awareness. As the region invests in mental health services and education, along with increasing acceptance of psychedelic therapies, it is emerging as a key contributor to the market's global expansion and development.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The psychedelic drugs market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for psychedelic drugs market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the psychedelic drugs market. The data is available for historic period 2016-2021.

Competitive Landscape and Psychedelic Drugs Market Share Analysis

The psychedelic drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.

Some of the major players operating in the market are:

  • Jazz Pharmaceuticals, Inc. (U.S.),
  • Janssen Pharmaceuticals, Inc. (U.S.)
  • Hikma Pharmaceuticals PLC (U.K.)
  • Compass (U.S.)
  • Verrian (Germany)
  • Pfizer Inc. (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Avadel (Ireland)
  • Celon Pharma SA.(Poland)
  • Cybin Corp. (Canada)
  • GH Research (Ireland)
  • Entheon Biomedical Corp (Canada)
  • PharmaTher Holdings Ltd. (India)
  • NRx Pharmaceuticals, Inc. (U.S.)
  • Usona Institute (U.S.)Top of Form

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Интерактивная панель анализа данных
  • Панель анализа компании для возможностей с высоким потенциалом роста
  • Доступ аналитика-исследователя для настройки и запросов
  • Анализ конкурентов с помощью интерактивной панели
  • Последние новости, обновления и анализ тенденций
  • Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Запросить демонстрацию

Содержание

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of GLOBAL Psychedelic drugs MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. type of Psychedelic drugs LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. MARKET APPLICATION COVERAGE GRID
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insight
  5. epidemiology
  6. REGULATORY FRAMEWORK: GLOBAL PSYCHEDELIC DRUGS MARKET
    1. REGULATORY SCENARIO IN INDIA
    2. REGULATORY SCENARIO IN UAE
    3. REGULATORY SCENARIO IN AFRICA
    4. REGULATORY SCENARIO IN THE U.S.
    5. REGULATORY SCENARIO IN BRAZIL
    6. REGULATORY SCENARIO IN THE U.K.
  7. Pipeline analysis
  8. market overview
    1. DRIVERS
      1. GROWING ACCEPTANCE OF PSYCHEDELIC DRUGS FOR TREATING DEPRESSION
      2. INCREASING PREVALENCE OF DEPRESSION AND MENTAL DISORDERS
      3. RISING AWARENESS TOWARDS MENTAL HEALTH
      4. ONGOING CLINICAL TRIALS
      5. RISE IN PRODUCT APPROVALS
    2. RESTRAINTS
      1. STRINGENT REGULATIONS FOR PSYCHEDELIC DRUGS
      2. HIGH COST OF PSYCHEDELIC DRUGS
      3. PATENT EXPIRY OF PSYCHEDELIC DRUGS
    3. OPPORTUNITIES
      1. INCREASING R&D ACTIVITIES IN PSYCHEDELIC DRUGS
      2. BREAKTHROUGH THERAPY DESIGNATION BY REGULATORY AUTHORITY
      3. UPCOMING REHABILITATION CENTERS
      4. AVAILABILITY OF CERTIFIED HEALTHCARE PROFESSIONALS
    4. CHALLENGES
      1. SIDE EFFECTS ASSOCIATED WITH PSYCHEDELIC DRUGS
      2. RISE IN ALTERNATIVES
      3. OTHER TREATMENT OPTIONS
  9. COVID-19 IMPACT ON GLOBAL PSYCHEDELIC DRUGS MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISIONS FOR MANUFACTURERS
    5. CONCLUSION
  10. global psychedelic drug market, BY source
    1. overview
    2. SYNTHETIC
    3. natural
  11. global psychedelic drugs MARKET, BY type
    1. overview
    2. empathogens
    3. dissociatives
    4. others
  12. global psychedelic drugs MARKET, BY drugs
    1. overview
    2. gamma-hydroxybutyric acid
    3. ketamine
    4. psilocybin
    5. others
  13. global psychedelic drugs MARKET, BY appplication
    1. overview
    2. narcolepsy
    3. Treatment resistant depression
    4. major depressive disorder
    5. opiate addiction
    6. post-traumatic stress disorder
    7. others
  14. global psychedelic drug market, BY route of administration
    1. overview
    2. oral
    3. inhalation
    4. injectable
  15. global psychedelic drugs MARKET, BY end user
    1. overview
    2. hospitals
    3. Specialty Clinics
    4. Homecare
    5. others
  16. global psychedelic drugs MARKET, BY distribution channel
    1. overview
    2. Hospital Pharmacy
    3. retail Pharmacy
    4. online Pharmacy
  17. GLOBAL Psychedelic Drugs MARKET, BY region
    1. Overview
    2. NORTH AMERICA
      1. u.s.
      2. canada
      3. mexico
    3. EUROPE
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. SPAIN
      6. Russia
      7. Poland
      8. Switzerland
      9. Netherlands
      10. Hungary
      11. Austria
      12. Norway
      13. Ireland
      14. Belgium
      15. Lithuania
      16. rest of europe
    4. middle east & africa
      1. Saudi Arabia
      2. israel
      3. EGYPT
      4. uae
  18. Global Psychedelic drugs market: COMPANY landscape
    1. company share analysis: global
    2. company share analysis: north america
    3. company share analysis: europe
    4. company share analysis: Middle East AND Africa
  19. swot
  20. company profile
    1. JAZZ PHARMACEUTICALS, INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. JANSSEN PHARMACEUTICALS, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON SERVICES, INC.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. Pfizer Inc.
      1. REVENUE ANALYSIS
      2. company share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    4. VERRIAN
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    5. AVADEL
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. RECENT DEVELOPMENTS
    6. Celon Pharma S.A.
      1. COMPANY SNAPSHOT
      2. PIPELINE PORTFOLIO
      3. RECENT DEVELOPMENTS
    7. COMPASS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. F. Hoffmann-La Roche Ltd
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    9. HIKMA PHARMACEUTICALS PLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    10. neuroRX, Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    11. PHARMATHER INC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    12. usonainstitute.org
      1. INSTITUTE SNAPSHOT
      2. PIPELINE PORTFOLIO
      3. RECENT DEVELOPMENTS
  21. questionnaire
  22. related reports

Список таблиц

TABLE 1 U.S. psychedelic drugs market, company wise pipeline analysis

TABLE 2 U.S. psychedelic drugs market, Research Institute pipeline analysis

TABLE 3 Psychedelics researches, in Europe

TABLE 4 Mental Illness in the U.S. adults, in 2018

TABLE 5 Mental Disorders, in the U.S. adults, in 2018

TABLE 6 More than one in six people in EU countries have a mental health problem

TABLE 7 Men are more likely to die from suicide, in all EU countries

TABLE 8 Mental Disorders causeD by usage of substance disorders, in world, in 2017

TABLE 9 Drug Development Pathway for FDA approval of New Medications

TABLE 10 The 1971 UN Convention on Psychotropic Substances

TABLE 11 cost of psychedelic drugs

TABLE 12 Total costs (direct and indirect) of mental health problems in EU countries, in million and as a share of GDP, In 2015

TABLE 13 psychedelic drugs R&D activities

TABLE 14 Global Psychedelic drug market, By source 2020-2028 (USD Million)

TABLE 15 Global Synthetic in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 16 Global Natural in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 17 global psychedelic drug market, By Type, 2020-2028 (USD Million)

TABLE 18 Global Empathogens in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 19 Global Dissociatives in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 20 Global Others in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 21 Global Therapy in Psychedelic Drugs Market, By Drugs, 2019-2028 (USD Million)

TABLE 22 Global Gamma-Hydroxybutyric Acid in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 23 Global Ketamine in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 24 Global Psilocybin in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 25 Global Others in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 26 Global application in psychedelic drugs Market, By Application, 2019-2028 (USD Million)

TABLE 27 Global Narcolepsy in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 28 Global Treatment Resistant Depression in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 29 Global Major Depressive Disorder in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 30 Global Opiate Addiction in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 31 Global Post-Traumatic Stress Disorder in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 32 Global Others in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 33 Global Psychedelic Drugs Market, By Route of Administration, 2019-2028 (USD Million)

TABLE 34 Global Oral in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 35 Global Inhalation in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 36 Global Injectable in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 37 global psychedelic drug market, By END USER, 2020-2028 (USD Million)

TABLE 38 Global Hospitals in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 39 Global Specialty Clinics in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 40 Global Homecare in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 41 Global Others in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 42 global medication & supplements in psychedelic drug market, By distribution channel, 2020-2028 (USD million)

TABLE 43 Global Hopitals Pharmacy in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 44 Global Retail Pharmacy in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 45 Global Online Pharmacy in Psychedelic Drugs Market, By Region, 2019-2028 (USD Million)

TABLE 46 GLOBAL Psychedelic Drugs MARKET, By Region, 2018-2027 (USD million)

TABLE 47 NORTH AMERICA PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 48 NORTH AMERICA PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 49 NORTH AMERICA PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 50 NORTH AMERICA PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 51 NORTH AMERICA PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 52 NORTH AMERICA PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 53 NORTH AMERICA PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 54 NORTH AMERICA PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 55 u.s.PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 56 u.s. PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 57 u.s. PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 58 u.s. PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 59 u.s. PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 60 u.s. PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 61 u.s. PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 62 canada PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 63 canada PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 64 canada PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 65 canada PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 66 canada PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 67 canada PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 68 canada PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 69 mexico PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 70 mexico PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 71 mexico PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 72 mexico PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 73 mexico PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 74 mexico PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 75 mexico PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 76 EUROPE PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 77 EUROPE PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 78 EUROPE PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 79 EUROPE PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 80 EUROPE PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 81 EUROPE PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 82 EUROPE PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 83 EUROPE PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 84 Germany PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 85 Germany PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 86 Germany PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 87 Germany PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 88 Germany PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 89 Germany PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 90 Germany PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 91 U.K. PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 92 U.K. PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 93 U.K. PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 94 U.K. PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 95 U.K. PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 96 U.K. PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 97 U.K. PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 98 France PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 99 France PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 100 France PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 101 France PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 102 France PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 103 France PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 104 France PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 105 Italy PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 106 Italy PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 107 Italy PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 108 Italy PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 109 Italy PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 110 Italy PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 111 Italy PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 112 spain PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 113 Spain PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 114 Spain PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 115 Spain PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 116 Spain PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 117 Spain PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 118 Spain PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 119 RUSSIA PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 120 Russia PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 121 Russia PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 122 Russia PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 123 Russia PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 124 Russia PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 125 Russia PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 126 Poland PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 127 Poland PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 128 Poland PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 129 Poland PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 130 Poland PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 131 Poland PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 132 Poland PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 133 Switzerland PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 134 Switzerland PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 135 Switzerland PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 136 Switzerland PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 137 Switzerland PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 138 Switzerland PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 139 Switzerland PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 140 Netherlands PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 141 Netherlands PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 142 Netherlands PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 143 Netherlands PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 144 Netherlands PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 145 Netherlands PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 146 Netherlands PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 147 Hungary PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 148 Hungary PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 149 Hungary PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 150 Hungary PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 151 Hungary PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 152 Hungary PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 153 Hungary PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 154 Austria PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 155 Austria PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 156 Austria PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 157 Austria PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 158 Austria PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 159 Austria PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 160 Austria PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 161 Norway PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 162 Norway PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 163 Norway PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 164 Norway PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 165 Norway PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 166 Norway PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 167 Norway PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 168 Ireland PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 169 Ireland PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 170 Ireland PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 171 Ireland PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 172 Ireland PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 173 Ireland PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 174 Ireland PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 175 Belgium PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 176 Belgium PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 177 Belgium PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 178 Belgium PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 179 Belgium PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 180 Belgium PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 181 Belgium PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 182 Lithuania PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 183 Lithuania PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 184 Lithuania PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 185 Lithuania PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 186 Lithuania PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 187 Lithuania PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 188 Lithuania PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 189 rest of europe PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 190 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 191 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 192 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 193 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 194 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 195 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 196 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 197 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 198 Saudi atrabia PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 199 Saudi Arabia PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 200 Saudi Arabia PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 201 Saudi Arabia PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 202 Saudi Arabia PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 203 Saudi Arabia PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 204 Saudi Arabia PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 205 israel PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 206 israel PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 207 israel PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 208 israel PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 209 israel PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 210 israel PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 211 israel PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 212 egypt PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 213 egypt PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 214 egypt PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 215 egypt PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 216 egypt PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 217 egypt PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 218 egypt PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

TABLE 219 UAE PSYCHEDELIC DRUGS Market, By SOURCE, 2019-2028 (USD MILLION)

TABLE 220 UAE PSYCHEDELIC DRUGS Market, By TYPE, 2019-2028 (USD Million)

TABLE 221 UAE PSYCHEDELIC DRUGS Market, By drugs, 2019-2028 (USD Million)

TABLE 222 UAE PSYCHEDELIC DRUGS Market, By application , 2019-2028 (USD Million)

TABLE 223 UAE PSYCHEDELIC DRUGS Market, By route of administration, 2019-2028 (USD Million)

TABLE 224 uae PSYCHEDELIC DRUGS Market, By end user, 2019-2028 (USD Million)

TABLE 225 UAE PSYCHEDELIC DRUGS Market, By distrubution channel, 2019-2028 (USD Million)

Список рисунков

FIGURE 1 Global PSYCHEDELIC DRUGS MARKET: SEGMENTATION

FIGURE 2 GLOBAL PSYCHEDELIC DRUGS MARKET : DATA TRIANGULATION

FIGURE 3 global Psychedelic drugs Market: DROC ANALYSIS

FIGURE 4 Global Psychedelic drugs market: Global VS REGIONAL MARKET ANALYSIS

FIGURE 5 Global Psychedelic drugs Market: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL Psychedelic drugs MARKET: MULTIVARIATE MODELLING

FIGURE 7 GLOBAL Psychedelic drugs MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 GLOBAL PSYCHEDELIC DRUGS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 GLOBAL psychedelic drugs Market: MARKET APPLICATION COVERAGE GRID

FIGURE 10 GLOBAL PSYCHEDELIC DRUGS MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 Global Psychedelic drugs market: SEGMENTATION

FIGURE 12 NORTH AMERICA is expected to DOMINATE THE GLOBAL Psychedelic drugs market GROWing WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 GROWING ACCEPTANCE OF PSYCHEDELIC DRUGS FOR TREATING DEPRESSION AND INCREASING PREVALENCE OF DEPRESSION AND MENTAL DISORDERS are DRIVing THE global Psychedelic drugs MARKET IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 14 SYNTHETIC SEGMENT is expected to account for the largest share of the global PSYCHEDELIC DRUGS MARKET in 2021 & 2028

FIGURE 15 North america is the fastest growing market FOR Psychedelic drugs MANUFACTURERS IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL PSYCHEDELIC DRUGS MARKET

FIGURE 17 MENTAL ILLNESS AMONG THE U.S. ADULTS, IN 2018, BY DEMOGRAPHIC GROUP

FIGURE 18 MENTAL ILLNESS TREATMENT RATES AMONG THE U.S. ADULTS, IN 2018, BY DEMOGRAPHIC GROUP

FIGURE 19 MENTAL ILLNESS TREATMENT RATES AMONG THE U.S. ADULTS, IN 2018, BY GENDER

FIGURE 20 PREVALENCE OF MENTAL HEALTH DISORDERS BY DISORDER TYPE, IN WORLD, IN 2017

FIGURE 21 MAGIC MUSHROOMS PRICES FOR RESEARCHERS, IN THE U.S.

FIGURE 22 global psychedelic drugs market: BY source, 2020

FIGURE 23 global psychedelic drugs market: BY source, 2021-2028 (USD Million)

FIGURE 24 global psychedelic drugs market: BY source, CAGR (2021-2028)

FIGURE 25 global psychedelic drugs market: BY source, LIFELINE CURVE

FIGURE 26 global psychedelic drugs market: BY type, 2020

FIGURE 27 global psychedelic drugs market: BY type, 2021-2028 (USD Million)

FIGURE 28 global psychedelic drugs market: BY type, CAGR (2021-2028)

FIGURE 29 global psychedelic drugs market: BY type, LIFELINE CURVE

FIGURE 30 global psychedelic drugs market: BY drugs, 2020

FIGURE 31 global psychedelic drugs market: BY drugs, 2021-2028 (USD Million)

FIGURE 32 global psychedelic drugs market: BY drugs, CAGR (2021-2028)

FIGURE 33 global psychedelic drugs market: BY drugs, LIFELINE CURVE

FIGURE 34 global psychedelic drugs market: BY application, 2020

FIGURE 35 global psychedelic drugs market: BY application, 2021-2028 (USD Million)

FIGURE 36 global psychedelic drugs market: BY applicaiton, CAGR (2021-2028)

FIGURE 37 global psychedelic drugs market: BY application, LIFELINE CURVE

FIGURE 38 global psychedelic drug market: BY route of administraiton, 2020

FIGURE 39 global psychedelic drug market: BY route of administration, 2020-2028 (USD Million)

FIGURE 40 global psychedelic drug market: BY route of administration, CAGR (2020-2028)

FIGURE 41 global psychedelic drug market: BY route of administration, LIFELINE CURVE

FIGURE 42 global psychedelic drug market: BY end user, 2020

FIGURE 43 global psychedelic drug market: BY end user, 2020-2028 (USD Million)

FIGURE 44 global psychedelic drug market: BY end user, CAGR (2020-2028)

FIGURE 45 global psychedelic drug market: BY end user, LIFELINE CURVE

FIGURE 46 global psychedelic drugs market: BY distribution channel, 2020

FIGURE 47 global psychedelic drugs market: BY distribution channel, 2020-2028 (USD Million)

FIGURE 48 global psychedelic drugs market: BY distribution channel, CAGR (2020-2028)

FIGURE 49 global psychedelic drugs market: BY distribution channel, LIFELINE CURVE

FIGURE 50 GLOBAL Psychedelic Drugs MARKET: SNAPSHOT (2020)

FIGURE 51 GLOBAL Psychedelic Drugs MARKET: BY Region (2020)

FIGURE 52 GLOBAL Psychedelic Drugs MARKET: BY Region (2020 & 2028)

FIGURE 53 GLOBAL Psychedelic Drugs MARKET: BY Region (2020 & 2028)

FIGURE 54 GLOBAL Psychedelic Drugs MARKET: BY type (2021-2028)

FIGURE 55 NORTH AMERICA PSYCHEDELIC DRUGS MARKET: SNAPSHOT (2020)

FIGURE 56 NORTH AMERICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020)

FIGURE 57 NORTH AMERICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 58 NORTH AMERICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 59 NORTH AMERICA PSYCHEDELIC DRUGS MARKET: BY SOURCE (2021-2028)

FIGURE 60 EUROPE PSYCHEDELIC DRUGS MARKET: SNAPSHOT (2020)

FIGURE 61 EUROPE PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020)

FIGURE 62 EUROPE PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 63 EUROPE PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 64 EUROPE PSYCHEDELIC DRUGS MARKET: BY SOURCE (2021-2028)

FIGURE 65 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: SNAPSHOT (2020)

FIGURE 66 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020)

FIGURE 67 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 68 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 69 MIDDLE EAST & AFRICA PSYCHEDELIC DRUGS MARKET: BY SOURCE (2021-2028)

FIGURE 70 Global Psychedelic drugs market: company share 2020 (%)

FIGURE 71 north america Psychedelic drugs market: company share 2020 (%)

FIGURE 72 europe Psychedelic drugs market: company share 2020 (%)

FIGURE 73 Middle East AND Africa Psychedelic drugs market: company share 2020 (%)

View Detailed Information Right Arrow

Методология исследования

Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.

Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.

Доступна настройка

Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.

Часто задаваемые вопросы

Rising Support for Psychedelic Therapy & Worldwide Shift Towards Psychedelic Legalization and Decriminalization are the growth drivers of the psychedelic drugs market.
Source, type, drugs, application, route of administration, end-user, and distribution channel are the factors on which the psychedelic drugs market research is based.
The major companies in the psychedelic drugs market are Jazz Pharmaceuticals, Inc. (U.S.), Janssen Pharmaceuticals, Inc. (U.S.), Hikma Pharmaceuticals PLC (U.K.), Compass (U.S.), Verrian (Germany), Pfizer Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Avadel (Ireland), Celon Pharma SA (Poland), Cybin Corp. (Canada), GH Research (Ireland), Entheon Biomedical Corp (Canada), PharmaTher Holdings Ltd. (India), NRx Pharmaceuticals, Inc. (U.S.), and Usona Institute (U.S.).
The psychedelic drugs market size will be worth USD 7.35 billion by 2031.
The psychedelic drugs market growth rate will be 13.3% by 2031.

Просмотр связанных страниц

Banner